New Hybrid Organic/Inorganic Polysilsesquioxane–Silica Particles as Sunscreens
Source abstract
Abstract
Effectiveness of organic sunscreens is limited by phototoxicity and degradation. Both of which can be significantly reduced by encapsulation in hollow particles or covalent incorporation into the solid structure of particles, but direct comparisons of the two methods have not been reported. In this study, physical encapsulation and covalent incorporation of sunscreens were compared with 1 mol % salicylate and curcumeroid sunscreens. 2-Ethylhexyl salicylate was physically encapsulated in hollow silica nanoparticles prepared by oil-in-water (O/W) microemulsion polymerizations (E-Sal). Some of these particles were coated with an additional shell or cap of silica to reduce leaking of sunscreen (cap-E-Sal). Covalent incorporation involved co-polymerizing tetraethoxysilane (TEOS) with 0.2 mol % of new salicylate and curcuminoid sunscreen monomers with triethoxsilyl groups. Particles were prepared with the salicylate attached to the silica matrix through single silsesquioxane groups (pendant; P-Sal) and two silsesquioxane groups (bridged; B-Sal). Particles based on a new curcuminoid-bridged monomer were also prepared (B-Curc). Sunscreen leaching, photodegradation, and sunscreen performance were determined for the E-Sal, cap-E-Sal, P-Sal, B-Sal, and B-Curc particles. Covalent attachment, particularly with bridged sunscreen monomers, reduced leaching and photodegradation over physical encapsulation, even with capping.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Skin Protection and Aging · Photodynamic Therapy Research Studies · Silicone and Siloxane Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Departments of Materials Science and Engineering and Chemistry and Biochemistry The University of Arizona, Tucson, Arizona 85721, United States
References (77)
Show source-provided references
1. Kochevar I. E. · 2003 · 1267
2. 10.1016/j.taap.2003.08.01910.1016/j.taap.2003.08.019 ↗
3. 10.1111/j.1600-0781.2001.170502.x10.1111/j.1600-0781.2001.170502.x ↗
4. 10.1111/1523-1747.ep1232551710.1111/1523-1747.ep12325517 ↗
5. 10.1111/1523-1747.ep1226535310.1111/1523-1747.ep12265353 ↗
6. 10.1111/1523-1747.ep1253171010.1111/1523-1747.ep12531710 ↗
7. Seite S. · Eur. J. Dermatol. · 1997 · 7 · 204
8. Fears T. R. · Cancer Res. · 2002 · 62 · 3992
9. 10.1038/bjc.2011.48610.1038/bjc.2011.486 ↗
10. 10.1016/j.jphotochemrev.2011.12.00110.1016/j.jphotochemrev.2011.12.001 ↗
11. 10.1016/1011-1344(95)07118-L10.1016/1011-1344(95)07118-L ↗
12. 10.1562/2004-02-12-RA-083.110.1562/2004-02-12-RA-083.1 ↗
13. 10.1111/j.1600-0536.1993.tb04543.x10.1111/j.1600-0536.1993.tb04543.x ↗
14. 10.1034/j.1398-9995.2002.1o3314.x10.1034/j.1398-9995.2002.1o3314.x ↗
15. 10.1111/j.0022-202X.2004.22725.x10.1111/j.0022-202X.2004.22725.x ↗
16. 10.1289/ehp.0110923910.1289/ehp.01109239 ↗
17. 10.1111/j.1751-1097.1998.tb09677.x10.1111/j.1751-1097.1998.tb09677.x ↗
18. 10.1016/j.tox.2004.06.04310.1016/j.tox.2004.06.043 ↗
19. 10.1016/j.tox.2004.02.01510.1016/j.tox.2004.02.015 ↗
20. 10.1016/j.foodchem.2009.12.00110.1016/j.foodchem.2009.12.001 ↗
21. 10.1016/j.ijpharm.2003.11.02910.1016/j.ijpharm.2003.11.029 ↗
22. 10.1081/PDT-20003145610.1081/PDT-200031456 ↗
23. 10.2174/15672010778036228510.2174/156720107780362285 ↗
24. 10.3109/02652048.2010.52009210.3109/02652048.2010.520092 ↗
25. 10.1016/S0731-7085(02)00433-810.1016/S0731-7085(02)00433-8 ↗
26. 10.3109/0363904090344973810.3109/03639040903449738 ↗
27. 10.1016/j.ejpb.2005.06.00210.1016/j.ejpb.2005.06.002 ↗
28. 10.1039/b608888k10.1039/b608888k ↗
29. Lapidot, N.; Magdassi, S.; Avnir, D.; Rottman, C.; Gans, O.; Seri-Levy, A.Sunscreen composition containing sol-gel microcapsules. US20020037261A1, 2002.
30. 10.1023/A:102078521789510.1023/A:1020785217895 ↗
31. 10.1039/C4TB01332H10.1039/C4TB01332H ↗
32. 10.1021/cr100161x10.1021/cr100161x ↗
33. 10.1039/c0jm04271d10.1039/c0jm04271d ↗
34. 10.1007/s13233-012-0114-210.1007/s13233-012-0114-2 ↗
35. 10.1590/S0100-4042201100060000610.1590/S0100-40422011000600006 ↗
36. 10.1016/S0927-7757(01)00510-610.1016/S0927-7757(01)00510-6 ↗
37. 10.1016/0927-7757(93)80244-910.1016/0927-7757(93)80244-9 ↗
38. 10.1021/la00048a01310.1021/la00048a013 ↗
39. 10.1016/0021-9797(68)90272-510.1016/0021-9797(68)90272-5 ↗
40. 10.1111/j.1467-2494.2005.00269.x10.1111/j.1467-2494.2005.00269.x ↗
41. 10.2109/jcersj2.123.78510.2109/jcersj2.123.785 ↗
42. 10.2310/6620.2006.0504610.2310/6620.2006.05046 ↗
43. 10.1111/j.1600-0536.2007.00942.x10.1111/j.1600-0536.2007.00942.x ↗
44. 10.2478/s11532-013-0361-x10.2478/s11532-013-0361-x ↗
45. 10.1016/j.addr.2008.03.01210.1016/j.addr.2008.03.012 ↗
46. 10.1155/2012/59395210.1155/2012/593952 ↗
47. 10.1021/ja01269a02310.1021/ja01269a023 ↗
48. 10.1021/ja01145a12610.1021/ja01145a126 ↗
49. 10.1021/je00030a03510.1021/je00030a035 ↗
50. Gounko, I. K.; Rakovich, Y.; Volkov, Y.; Dongegan, J.; Kelleher, D.; Mitchell, S.Targeted Nanoparticles for Drug Delivery. WO2005105035A2, 2005.
51. 10.1002/jhet.557031044410.1002/jhet.5570310444 ↗
52. 10.1021/ac060113m10.1021/ac060113m ↗
53. 10.1016/j.micromeso.2009.06.02810.1016/j.micromeso.2009.06.028 ↗
54. 10.1021/la803546r10.1021/la803546r ↗
55. 10.1111/j.1467-2494.1996.tb00145.x10.1111/j.1467-2494.1996.tb00145.x ↗
56. Mansur J. S. · An. Bras. Dermatol. · 1986 · 61 · 121
57. 10.1111/j.1751-1097.1979.tb07090.x10.1111/j.1751-1097.1979.tb07090.x ↗
58. 10.1111/j.1468-2494.2012.00748.x10.1111/j.1468-2494.2012.00748.x ↗
59. 10.1111/j.1467-2494.1994.tb00082.x10.1111/j.1467-2494.1994.tb00082.x ↗
60. 10.1046/j.1467-2494.1999.203163.x10.1046/j.1467-2494.1999.203163.x ↗
61. 10.1016/j.ijpharm.2011.01.04010.1016/j.ijpharm.2011.01.040 ↗
62. 10.1016/S0003-2670(98)00577-710.1016/S0003-2670(98)00577-7 ↗
63. 10.1080/0148391880806720010.1080/01483918808067200 ↗
64. 10.1016/j.jaad.2008.07.04310.1016/j.jaad.2008.07.043 ↗
65. Arkles, B. C.Curcumin and its derivatives for use as silicone colorants. US20070204412A1, 2007.
66. 10.1007/BF0243694210.1007/BF02436942 ↗
67. 10.1021/cm011074s10.1021/cm011074s ↗
68. Food and Drug Administration. Labeling and effectivenesstesting; sunscreen drug products for over-the-counter human use. Finalrule. In Federal Register:Washington, DC, USA, 2011; Vol.76, pp35620–35665.
69. 10.1371/journal.pone.000893310.1371/journal.pone.0008933 ↗
70. 10.1039/p1973000124410.1039/p19730001244 ↗
71. 10.1021/cr00037a01310.1021/cr00037a013 ↗
72. 10.1111/j.1467-2494.1987.tb00485.x10.1111/j.1467-2494.1987.tb00485.x ↗
73. 10.1111/j.1468-2494.2008.00482.x10.1111/j.1468-2494.2008.00482.x ↗
74. 10.1016/j.ijpharm.2012.02.00110.1016/j.ijpharm.2012.02.001 ↗
75. Diffey B. L. · J. Soc. Cosmet. Chem. · 1989 · 40 · 127
76. 10.1111/j.0412-5463.2004.00207.x10.1111/j.0412-5463.2004.00207.x ↗
77. Osterwalder U. · Australas. J .Dermatol. · 2012 · 53 · 46